
Denmark's Novo Nordisk Outsources Drug R&D as US Firms Patent the AI Layer Beneath Biology
MindWalk Holdings filed a new patent on July 15 extending its HYFT biological-pattern technology, while NVIDIA deepens lab partnerships with Thermo Fisher and Eli Lilly. Denmark's Novo Nordisk closed its cell therapy unit and licensed a Parkinson's asset to an AI platform instead, signaling European pharma is renting US-built AI infrastructure rather than owning it.
























